| |
| |
|
| Insider
Information: |
Junius Daniel M |
| Relationship: |
|
| City: |
Groton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
286,488 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,459,798 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
286,488 |
|
|
| Total
Value |
$7,459,798 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
7
|
|
Stock
price went up :
|
2
|
4
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
1.3
|
| Percentage
Gain/Loss : |
 21.7%
|
95.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2018-03-16 |
184,987 |
2007-08-15 |
0 |
Premium* |
|
|
Idexx Laboratories Inc |
IDXX |
Director |
2024-01-30 |
3,042 |
|
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
98,459 |
2016-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2013-09-03 |
4 |
OE |
$5.74 |
$95,669 |
D/D |
16,667 |
90,003 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2013-09-03 |
4 |
AS |
$16.43 |
$273,772 |
D/D |
(16,667) |
73,336 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2014-09-19 |
4 |
OE |
$5.74 |
$99,997 |
D/D |
17,421 |
98,057 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2020-03-09 |
4 |
B |
$3.40 |
$68,000 |
D/D |
20,000 |
38,000 |
2.39 |
% |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2022-11-17 |
4 |
B |
$1.87 |
$37,400 |
D/D |
20,000 |
63,250 |
2.39 |
% |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2011-09-20 |
4 |
OE |
$3.19 |
$77,008 |
D/D |
23,336 |
73,336 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-13 |
4 |
OE |
$4.29 |
$107,250 |
D/D |
25,000 |
221,700 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-20 |
4 |
S |
$11.68 |
$292,000 |
D/D |
(25,000) |
196,700 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-03-16 |
4 |
OE |
$4.29 |
$107,250 |
D/D |
25,000 |
209,987 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-03-16 |
4 |
S |
$12.02 |
$300,405 |
D/D |
(25,000) |
184,987 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2015-04-02 |
4 |
OE |
$5.74 |
$149,998 |
D/D |
26,132 |
124,189 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2016-06-02 |
4 |
OE |
$3.19 |
$86,401 |
D/D |
27,085 |
196,700 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2023-05-10 |
4 |
B |
$1.56 |
$46,800 |
D/D |
30,000 |
93,250 |
2.39 |
% |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2015-05-01 |
4 |
OE |
$5.74 |
$202,708 |
D/D |
35,315 |
166,473 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2015-05-01 |
4 |
AS |
$8.36 |
$295,198 |
D/D |
(35,315) |
131,158 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-13 |
4 |
S |
$10.01 |
$467,253 |
D/D |
(46,667) |
196,700 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-02-13 |
4 |
OE |
$3.30 |
$154,001 |
D/D |
46,667 |
243,367 |
0 |
- |
|
117 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
